Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Lovastatin in brain arteriovenous malformations
NCT04297033Phase 2Unknown
- Sponsor
- Beijing Tiantan Hospital
- Start
- Jan 2021
- Primary completion
- Jun 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of lovastatin in cerebral arteriovenous malformation (AVM), sponsored by Beijing Tiantan Hospital. Status: unknown.
02
Drugs
lovastatin
03
Conditions
cerebral arteriovenous malformation (AVM)
Beyond the preview
Go deeper on NCT04297033.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04297033.